Sterile Injectable Drugs Market Analysis

  • Report ID: 3050
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Sterile Injectable Drugs Market Analysis

The market is segmented by drug class into insulin, hormones, vaccines, peptide antibiotic, cytokines, and others, out of which, the vaccines segment is anticipated to hold the largest share in the market during the forecast period on account of escalating demand for vaccines for various infectious diseases, with respect to the spread of coronavirus, and other viral and bacterial diseases, including smallpox, measles, rubella, polio, and others. The insulin segment is also anticipated to witness major market share over the forecast period, owing to the rising cases of type 1 and type 2 diabetes. 

On the basis of distribution channel, the market is segmented into hospitals, pharmacy, ambulatory surgical centers, and others. Out of these, the hospitals segment is anticipated to witness highest CAGR over the forecast period on the back of higher patient pool, ease of availability, and greater credibility of hospitals over general pharmacies.

Our in-depth analysis of the global market includes the following segments:

           By Type

  • Small Molecule
  • Large Molecule

             By Drug Class

  • Insulin
  • Hormones
  • Vaccines
  • Peptide Antibiotics
  • Cytokines
  • Others

 

 

           By Application

  • Pain
  • Infections
  • Autoimmune Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Other

           By Distribution Channel

  • Hospitals
  • Pharmacy
  • Ambulatory Surgical Centers
  • Others
 

 

 

 

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3050
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of sterile injectable drugs is evaluated at USD 663.79 billion.

Sterile Injectable Drugs Market size was valued at USD 636.21 billion in 2024 and is set to exceed USD 1.21 trillion by 2037, registering over 5.1% CAGR during the forecast period i.e., between 2025-2037.

North America industry is likely to dominate majority revenue share by 2037, led by high investment in healthcare sector, along with increasing medical R&D activities in the region.

The major players in the market are GlaxoSmithKline plc, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, AbbVie Inc., Amgen Inc., Novartis AG, Progenity, Inc., Johnson & Johnson Services, Inc. and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample